Tretinoin

Tɛmplet:Infobox drug/title
Names
Pronunciation	See pronunciation note
Trade names	Vesanoid, Avita, Renova, others
	IUPAC name (2E,4E,6E,8E)-3,7-Dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoic acid;
Clinical data
WHO AWaRe	Script error: No such module "WDfetch".
Pregnancy; category	Tɛmplet:Infobox drug/pregnancy category
Routes of; use	Topical, by mouth
Defined daily dose	Not established
External links
AHFS/Drugs.com	Systemic: Tɛmplet:Drugs.com; Topical: Tɛmplet:Drugs.com
MedlinePlus	a608032
Legal
[[Regulation of therapeutic goods \|Tɛmplet:Engvar data]]	Tɛmplet:Infobox drug/licence
Legal status	Tɛmplet:Infobox drug/legal status
Pharmacokinetics
Protein binding	> 95%
Elimination half-life	0.5-2 hours
Identifiers
PubChem CID	Tɛmplet:Infobox drug/formatPubChemCID; Tɛmplet:Infobox drug/formatPubChemCID;
PubChem SID	Tɛmplet:Infobox drug/formatPubChemSID; Tɛmplet:Infobox drug/formatPubChemSID;
IUPHAR/BPS	Tɛmplet:Infobox drug/formatIUPHARBPS; Tɛmplet:Infobox drug/formatIUPHARBPS;
DrugBank	Tɛmplet:Infobox drug/formatDrugBank; Tɛmplet:Infobox drug/formatDrugBank;
ChemSpider	Tɛmplet:Infobox drug/formatChemSpider; Tɛmplet:Infobox drug/formatChemSpider;
KEGG	Tɛmplet:Infobox drug/formatKEGG; Tɛmplet:Infobox drug/formatKEGG;
ChEBI	Tɛmplet:Infobox drug/formatChEBI; Tɛmplet:Infobox drug/formatChEBI;
ChEMBL	Tɛmplet:Infobox drug/formatChEMBL; Tɛmplet:Infobox drug/formatChEMBL;
NIAID ChemDB	Tɛmplet:Infobox drug/formatChemDBNIAID; Tɛmplet:Infobox drug/formatChemDBNIAID;
PDB ligand	Tɛmplet:Infobox drug/formatPDBligand; Tɛmplet:Infobox drug/formatPDBligand;
CompTox Dashboard (EPA)	Tɛmplet:Infobox drug/formatCompTox; Tɛmplet:Infobox drug/formatCompTox;
Chemical and physical data
Formula	Tɛmplet:Infobox drug/chemical formula
Molar mass	Tɛmplet:Chem molar mass
3D model (JSmol)	Tɛmplet:Infobox drug/formatJmol; Tɛmplet:Infobox drug/formatJmol;
Melting point	180 °C (356 °F)
	SMILES CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C;
	InChI InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+Tɛmplet:Stdinchicite; Key:SHGAZHPCJJPHSC-YCNIQYBTSA-NTɛmplet:Stdinchicite;

Tɛmplet:Infobox drug/maintenance categories

Tretinoin, bɛ lahi mi tila shɛli all-trans retinoic acid (ATRA), nyɛla tila shɛli din tibiri ningbuŋ bin tɔra din nye acne la, nti pahi acute promyelocytic leukemia din nye ʒim doro la.^[2]^[3]^[4] Di kana ningbuŋ bin tɔra din nye acne la, tibbu polo, bɛ mali mi m ʒɛri ningbuŋ maa ka mani kpam ni ʒƐri shɛm.^[4]

References

↑ WHOCC - ATC/DDD Index.
↑ Tretinoin. The American Society of Health-System Pharmacists.
↑ Tivnan, Amanda (2016). Resistance to Targeted Therapies Against Adult Brain Cancers. Springer. p. 123. ISBN 9783319465050. Archived from the original on 2017-11-05. Retrieved 2016-12-20.
1 2 British national formulary : BNF 69 (69 ed.). British Medical Association. 2015. pp. 627, 821–822. ISBN 9780857111562.

[who-1] WHOCC - ATC/DDD Index.

[AHFS20162-2] Tretinoin. The American Society of Health-System Pharmacists.

[Tiv20162-3] Tivnan, Amanda (2016). Resistance to Targeted Therapies Against Adult Brain Cancers. Springer. p. 123. ISBN 9783319465050. Archived from the original on 2017-11-05. Retrieved 2016-12-20.

[BNF692-4] 1 2 British national formulary : BNF 69 (69 ed.). British Medical Association. 2015. pp. 627, 821–822. ISBN 9780857111562.

[1]

[2]

[3]

[4]